---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-22-079487"
form_type: "8-K"
ticker: "INM"
cik: "0001728328"
company_name: "InMed Pharmaceuticals Inc."
filed_at: "2022-12-13T23:59:59+00:00"
generated_at: "2026-06-21T05:33:23.191684+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# InMed appoints interim CFO and replaces auditor KPMG with Marcum

## Summary
- Jonathan Tegge appointed Interim CFO via Brio; monthly fee $9,750. Effective Dec 12, 2022.
- KPMG resigned as auditor (Dec 8, 2022); InMed engaged Marcum LLP as replacement, subject to acceptance.
- Annual Meeting Dec 15, 2022; management to recommend Marcum appointment using discretionary proxy.
- Options granted: 1,400 fully vested shares to Brio; 1,400 shares vesting monthly over 12 months to Tegge.

## SEC filing metadata
- accession: 0001213900-22-079487
- form_type: 8-K
- ticker: INM
- cik: 0001728328
- company_name: InMed Pharmaceuticals Inc.
- filed_at: 2022-12-13T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1728328/000121390022079487/0001213900-22-079487-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1728328/000121390022079487/ea170120-8k_inmedpharma.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-22-079487
- JSON: https://secwatch.observer/filing/0001213900-22-079487.json
- Plain text: https://secwatch.observer/filing/0001213900-22-079487.txt

## Key facts
- Executive change
  Jonathan Tegge was appointed as Interim Chief Financial Officer at InMed Pharmaceuticals Inc..
  - Action: appointed
  - Role: Interim Chief Financial Officer
  source text: As described above, the Company appointed Mr. Tegge as Interim Chief Financial Officer of the Company effective December 12, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1728328/000121390022079487/0001213900-22-079487-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.